Timothy Daley
Stock Analyst at Wells Fargo
(2.08)
# 2,896
Out of 5,182 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $44 | $41.03 | +8.36% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.75 | +321.05% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $88.94 | +6.81% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $36.76 | +95.87% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $115.48 | +25.56% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,259.94 | +3.18% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $304.24 | -6.32% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $191.12 | +29.24% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $173.89 | +58.15% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $273.72 | -1.36% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $9.41 | +197.56% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $13.73 | +154.92% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $491.46 | +5.81% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.27 | +3,273.31% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $117.78 | +57.07% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $75.65 | +12.36% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $173.26 | +26.98% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $114.19 | +92.66% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $7.90 | +254.43% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $198.02 | -29.30% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $53.13 | +69.40% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $44
Current: $41.03
Upside: +8.36%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.75
Upside: +321.05%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $88.94
Upside: +6.81%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $36.76
Upside: +95.87%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $115.48
Upside: +25.56%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,259.94
Upside: +3.18%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $304.24
Upside: -6.32%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $191.12
Upside: +29.24%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $173.89
Upside: +58.15%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $273.72
Upside: -1.36%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $9.41
Upside: +197.56%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $13.73
Upside: +154.92%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $491.46
Upside: +5.81%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.27
Upside: +3,273.31%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $117.78
Upside: +57.07%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $75.65
Upside: +12.36%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $173.26
Upside: +26.98%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $114.19
Upside: +92.66%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $7.90
Upside: +254.43%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $198.02
Upside: -29.30%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $53.13
Upside: +69.40%